# LIMS-to-QMS Assay Validation Bridge

**Niche:** [[niches/medical-device-mfg/ivd-diagnostic-instruments/profile|IVD Diagnostic Instrument Makers]]
**Industry:** [[industries/medical-device-mfg|Medical Device Manufacturing]]
**Type:** Buy & Customize (Vertical Adaptation)
**One-liner:** LIMS platforms (LabVantage, STARLIMS) manage assay testing data and QMS platforms (MasterControl, Veeva) manage validation documents, but neither connects assay test results to the validation protocol they satisfy — forcing quality engineers to manually cross-reference testing data with protocol acceptance criteria.
**Tags:** #data-integration #compliance #automation

## The Problem
An IVD assay validation protocol specifies acceptance criteria across precision, accuracy, linearity, reportable range, interfering substances, and stability — typically 50-100 individual acceptance criteria per assay. The testing data that demonstrates compliance with these criteria is generated in LIMS over weeks of laboratory work. Quality engineers must manually map each LIMS test result to the specific protocol acceptance criterion it satisfies, verify that results meet criteria, and compile the validation report. This cross-referencing takes 20-40 hours per validation and is error-prone — mismatched test-to-criterion mappings are a common audit finding.

## What Already Exists
LIMS platforms manage sample workflows, test execution, and results storage effectively. QMS platforms manage validation protocol templates, review/approval workflows, and document control. Both systems work well independently. Integration platforms (MuleSoft, Boomi) can move data between systems but have no understanding of the semantic relationship between a LIMS test result and a validation protocol acceptance criterion.

## The Customization Gap
The bridge must understand IVD validation protocol structure — that a precision study result (CV% across 20 replicates at 3 concentration levels) maps to acceptance criterion 4.2.1 in the protocol, not just to a generic "precision" field. It must handle protocol-specific acceptance criteria formats (e.g., "CV% < 5% at Level 1, < 8% at Level 2, < 10% at Level 3"), auto-evaluate pass/fail against each criterion, and generate the validation summary report in the format expected by FDA reviewers. This semantic mapping layer is IVD-specific and does not exist in any integration platform.

## Target Customer
Quality engineers and validation specialists at IVD companies running 10+ assay validations per year. Approximately 150-200 US IVD manufacturers at this scale.

## Impact If Solved
Validation report compilation drops from 20-40 hours to 2-4 hours per assay. Criterion-to-result mapping errors (a common FDA audit finding) are eliminated. Validation project timelines compress by 1-2 weeks per assay.
